Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents.
Contributors: Canadian Coordinating Office for Health Technology Assessment.
Series: Technology overview -- issue 9; Technology overview (Ottawa, Ont. : 1998) -- issue 9.
Publisher: Canadian Coordinating Office for Health Technology Assessment
Published: 2003
Place of publication: Ottawa
Language: eng
Number of pages: 17
Subjects: Diabetes -- Chemotherapy.; Hypoglycemic agents.
Other titles: Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents.
Notes: Based on Technology report, no. 29, entitled: Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents : systematic review and budget impact analysis.

"April 2003."

Includes bibliographical references.